Meet with our product experts in one-on-one virtual sessions and get a deep insight into our API Pharma Products offerings.

Our experts will answer your questions, provide advice, and help you understand our product better.

Set up a meeting

Verified

About Us:

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products – Dr. Reddy’s is an active pharmaceutical ingredient supplier for foremost formulators and offers a portfolio of products and services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations.

As an active pharmaceutical ingredient manufacturer, our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, Europe, India, Russia, and other CIS countries.

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of 'Excellence in Pharma: Sustainability'

At CPHI 2020 - We are honoured that our sustainability initiative has been recognized with the CPhI Pharma Award 2020 in the category of ‘Excellence..

At CPHI 2021 - Dr. Reddy's have been shortlisted for Excellence in Pharma

At CPHI 2021 - Dr. Reddys have been shortlisted for Excellence in Pharma: Regulatory Procedures and Compliance

The Portfolio of Dr. Reddy’s API Offerings

The Portfolio of Dr. Reddy’s API Offerings

Our Team

Aviso Legal

Nenhuma informação neste catálogo - incluindo qualquer referência a qualquer produto ou serviço - constitui uma oferta de venda ou deve ser interpretada como uma oferta de venda. Os produtos protegidos por patentes válidas não são oferecidos ou fornecidos para uso comercial. No entanto, as quantidades de pesquisa de tais produtos podem ser oferecidas para fins de submissão regulatória, onde quer que existam tais isenções regulatórias. Os compradores devem fazer sua avaliação independente do cenário de patentes para seus respectivos mercados e serão responsáveis por todas as responsabilidades relacionadas à patente. Os produtos protegidos por patentes válidas na Índia não estão disponíveis para uso comercial, mas estariam disponíveis para os propósitos da Seção 107A.